"Redefining Aging: The Potential of Rapamycin"
Originally Published 1 year ago — by SciTechDaily
Rapamycin, a drug used in cancer treatment and post-organ transplant care, has shown promise in extending both lifespan and health span in lab animals by targeting the endolysosomal system and reducing age-related inflammation. Researchers have identified the mechanisms by which rapamycin extends lifespan, including increased autophagy and decreased activity of the protein S6K. Understanding these mechanisms is crucial for preventing unwanted side effects and potentially redefining aging.